ISL
HALO icon

Ingalls & Snyder LLC’s Halozyme HALO Stock Holding History

Ingalls & Snyder LLC’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$574K Hold
7,339
– – 0.02% 281
2026
Q1 		$474K Buy
7,339
+2,000
+37% +$141K 0.02% 302
2025
Q4 		$359K Sell
5,339
-73
-1% -$4.91K 0.01% 342
2025
Q3 		$397K Buy
+5,412
New +$359K 0.01% 328
2021
Q1 		– Sell
-8,180
Closed -$349K – 443
2020
Q4 		$349K Sell
8,180
-4,475
-35% -$161K 0.02% 326
2020
Q3 		$333K Hold
12,655
– – 0.02% 281
2020
Q2 		$339K Buy
+12,655
New +$285K 0.02% 306

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ingalls & Snyder LLC's HALO Position: Q2 2026 in Review

Ingalls & Snyder LLC held its Halozyme (HALO) position steady in Q2 2026 at 7,339 shares worth $574K. The position accounts for 0.02% of the portfolio, ranked #281.

Ingalls & Snyder LLC first reported a position in HALO in Q2 2020 and has held it in 7 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Ingalls & Snyder LLC held 7,339 shares of Halozyme worth $574K as of Q2 2026.
  • Ingalls & Snyder LLC left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.02% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #281 holding.
  • Ingalls & Snyder LLC first reported a position in Halozyme in Q2 2020 and has held it in 7 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.